Zentalis Market Capitalization vs Average Assets Analysis

ZNTL Stock  USD 15.19  1.10  7.81%   
Trend analysis of Zentalis PharmaceuticalsLlc balance sheet accounts such as Total Assets of 378.6 M, Other Current Liab of 29.2 M, Total Current Liabilities of 40.3 M or Total Stockholder Equity of 306.3 M provides information on Zentalis PharmaceuticalsL's total assets, liabilities, and equity, which is the actual value of Zentalis PharmaceuticalsL to its prevalent stockholders. By breaking down trends over time using Zentalis PharmaceuticalsL balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

About Zentalis Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Zentalis PharmaceuticalsL at a specified time, usually calculated after every quarter, six months, or one year. Zentalis PharmaceuticalsL Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Zentalis PharmaceuticalsL and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Zentalis currently owns. An asset can also be divided into two categories, current and non-current.

Zentalis PharmaceuticalsL Balance Sheet Chart

Zentalis PharmaceuticalsL Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Zentalis PharmaceuticalsL uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Zentalis PharmaceuticalsL's Net Receivables is quite stable compared to the past year. Property Plant And Equipment Gross is expected to rise to about 47.1 M this year, although the value of Other Current Liabilities will most likely fall to about 29.2 M.

Total Assets

Total assets refers to the total amount of Zentalis PharmaceuticalsL assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Zentalis PharmaceuticalsL books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Zentalis PharmaceuticalsL balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Zentalis PharmaceuticalsLlc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Zentalis PharmaceuticalsL's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zentalis PharmaceuticalsL current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Tax Provision is expected to rise to about (784.7 K) this year. The value of Selling General Administrative is expected to slide to about 38 M
 2010 2019 2023 2024 (projected)
Interest Income355K498K572.7K469.2K
Net Interest Income355K498K572.7K469.2K

Zentalis PharmaceuticalsL fundamental ratios Correlations

0.980.981.00.110.960.910.52-0.880.990.40.880.360.911.00.84-0.47-0.870.940.920.990.980.961.00.761.0
0.981.00.960.220.930.920.58-0.920.980.330.870.380.930.970.89-0.51-0.830.980.960.991.00.990.960.750.97
0.981.00.970.190.940.920.58-0.920.990.340.870.420.930.980.89-0.52-0.840.980.960.991.00.990.970.770.98
1.00.960.970.10.960.890.48-0.870.980.420.860.350.91.00.81-0.46-0.880.920.890.980.970.941.00.741.0
0.110.220.190.1-0.030.02-0.33-0.130.070.42-0.05-0.13-0.010.130.050.05-0.330.310.080.130.190.140.14-0.250.13
0.960.930.940.96-0.030.860.65-0.940.960.270.830.50.970.960.9-0.66-0.820.890.880.950.940.920.950.810.96
0.910.920.920.890.020.860.61-0.820.910.330.990.250.890.870.86-0.39-0.740.890.980.950.90.960.890.810.88
0.520.580.580.48-0.330.650.61-0.720.57-0.480.560.410.770.490.82-0.63-0.140.530.670.590.570.630.450.60.5
-0.88-0.92-0.92-0.87-0.13-0.94-0.82-0.72-0.91-0.18-0.76-0.63-0.98-0.88-0.970.80.75-0.93-0.88-0.89-0.92-0.91-0.86-0.81-0.88
0.990.980.990.980.070.960.910.57-0.910.340.870.480.930.980.86-0.53-0.850.950.940.980.990.970.980.820.98
0.40.330.340.420.420.270.33-0.48-0.180.340.370.060.160.390.080.0-0.760.390.250.330.330.30.470.280.39
0.880.870.870.86-0.050.830.990.56-0.760.870.370.210.850.840.81-0.34-0.730.840.950.920.850.920.870.810.84
0.360.380.420.35-0.130.50.250.41-0.630.480.060.210.530.380.52-0.85-0.40.460.350.310.420.390.360.720.38
0.910.930.930.9-0.010.970.890.77-0.980.930.160.850.530.90.98-0.73-0.740.910.920.930.920.930.890.840.9
1.00.970.981.00.130.960.870.49-0.880.980.390.840.380.90.82-0.48-0.880.930.890.980.980.950.990.731.0
0.840.890.890.810.050.90.860.82-0.970.860.080.810.520.980.82-0.76-0.650.890.90.880.880.910.810.810.83
-0.47-0.51-0.52-0.460.05-0.66-0.39-0.630.8-0.530.0-0.34-0.85-0.73-0.48-0.760.45-0.55-0.46-0.46-0.52-0.5-0.45-0.69-0.48
-0.87-0.83-0.84-0.88-0.33-0.82-0.74-0.140.75-0.85-0.76-0.73-0.4-0.74-0.88-0.650.45-0.85-0.73-0.83-0.84-0.8-0.91-0.68-0.88
0.940.980.980.920.310.890.890.53-0.930.950.390.840.460.910.930.89-0.55-0.850.940.950.980.970.930.770.93
0.920.960.960.890.080.880.980.67-0.880.940.250.950.350.920.890.9-0.46-0.730.940.960.940.990.890.810.89
0.990.990.990.980.130.950.950.59-0.890.980.330.920.310.930.980.88-0.46-0.830.950.960.980.980.980.750.98
0.981.01.00.970.190.940.90.57-0.920.990.330.850.420.920.980.88-0.52-0.840.980.940.980.980.970.750.98
0.960.990.990.940.140.920.960.63-0.910.970.30.920.390.930.950.91-0.5-0.80.970.990.980.980.940.80.95
1.00.960.971.00.140.950.890.45-0.860.980.470.870.360.890.990.81-0.45-0.910.930.890.980.970.940.740.99
0.760.750.770.74-0.250.810.810.6-0.810.820.280.810.720.840.730.81-0.69-0.680.770.810.750.750.80.740.73
1.00.970.981.00.130.960.880.5-0.880.980.390.840.380.91.00.83-0.48-0.880.930.890.980.980.950.990.73
Click cells to compare fundamentals

Zentalis PharmaceuticalsL Account Relationship Matchups

Zentalis PharmaceuticalsL fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets102.7M365.6M454.5M539.3M562.0M378.6M
Other Current Liab9.8M19.0M30.9M45.4M51.5M29.2M
Total Current Liabilities14.9M28.6M43.9M56.6M69.4M40.3M
Total Stockholder Equity76.8M333.4M364.5M434.0M437.3M306.3M
Other Liab4.2M2.5M1.6M3.5M3.1M2.3M
Net Tangible Assets(92.6M)296.0M360.2M433.8M498.9M523.8M
Property Plant And Equipment Net2.8M3.6M52.8M50.1M41.7M27.8M
Net Debt(81.6M)(53.0M)(13.8M)2.1M17.7M18.6M
Retained Earnings(83.0M)(200.8M)(359.6M)(596.4M)(888.6M)(844.1M)
Accounts Payable4.3M8.7M11.6M11.2M14.9M9.9M
Cash82.4M55.0M59.7M43.1M28.0M39.1M
Non Current Assets Total18.6M20.5M103.7M87.4M65.3M56.8M
Non Currrent Assets Other2.2M2.3M2.6M(1.8M)6.8M7.2M
Other Assets0.04.3M9.7M12.4M14.2M14.9M
Cash And Short Term Investments82.4M338.5M339.9M437.4M482.9M312.8M
Net Receivables140K417K4.4M7.0M8.1M8.5M
Common Stock Total Equity25K41K45K59K53.1K50.4K
Common Stock Shares Outstanding32.9M28.1M42.7M52.9M65.4M44.0M
Liabilities And Stockholders Equity102.7M365.6M454.5M539.3M562.0M378.6M
Non Current Liabilities Total4.2M3.6M46.1M48.6M55.3M29.4M
Capital Lease Obligations781K2.0M45.9M45.2M43.2M25.1M
Other Current Assets1.5M6.2M10.9M14.6M13.8M8.7M
Other Stockholder Equity159.7M534.1M724.1M1.0B1.3B691.8M
Total Liab19.1M32.2M90.0M105.3M124.6M69.6M
Net Invested Capital76.8M308.6M364.0M433.8M437.3M290.6M
Property Plant And Equipment Gross2.8M3.6M53.6M7.7M44.9M47.1M
Total Current Assets84.1M345.1M350.8M451.9M496.7M321.8M
Accumulated Other Comprehensive Income(141.7M)36K(125K)(1.4M)2.2M2.3M
Capital Stock25K41K45K59K70K66.5K
Net Working Capital69.2M316.5M306.8M395.3M427.4M281.5M
Common Stock25K41K45K59K70K66.5K
Property Plant Equipment2.8M3.6M8.1M7.7M8.9M5.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Zentalis Stock analysis

When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.47)
Return On Assets
(0.29)
Return On Equity
(0.67)
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.